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4.27.1 Introduction
Addiction affects millions of compulsive drug users around the world. It contributes to or causes severe health problems, such as
cancer (tobacco), heart disease (tobacco and stimulants), liver disease (alcohol), HIV (needle sharing), and death (tobacco, opioids,
and alcohol). It is associated with major social problems, including organized, property, violent crime, accidents, poverty,
homelessness, and incarceration. Addiction is construed as a chronic disease characterized by cyclical periods of intense use
(compulsive drug use and compulsive drug seeking), quitting, the emergence of an abstinence syndrome that includes a brief
physical withdrawal and a persistent negative emotional state (e.g., dysphoria, anxiety, irritability), cravings, and relapse (Jaffe,
1980; Koob and Volkow, 2016, 2010).
While drug use involves the direct pharmacological action of the drug, drug seeking and relapse occur when the drug is no longer
physiologically active; relapse rates are often around 50% in unmedicated individuals even after detoxiﬁcation and protracted
abstinence (McLellan et al., 2000). As such, addiction has been thought of as a neuroadaptive process (Everitt et al., 2008; Everitt
and Robbins, 2016; Hyman and Malenka, 2001; Kelley, 2004; Volkow et al., 2003; White, 1996). The ﬁelds of neurobiology of
addiction and the neurobiology of learning and memory have identiﬁed shared neurocircuitry, molecular substrates, and plasticity
mechanisms. Many theories of addiction now include principles of classical and instrumental learning and multiple memory
systems to explain the persistent behavioral phenomena observed in addiction (Everitt and Robbins, 2016; Koob and Volkow,
2016). The overall hypothesis that addiction persists as a memory or memory-like process long after drug exposure has become
widely accepted (Everitt and Robbins, 2016; Hyman, 2005; Hyman and Malenka, 2001; McLellan et al., 2000; Nestler, 2001;
Robinson and Berridge, 2008; White, 1996), even if the evidence for it is somewhat limited. The aim of this chapter is to describe
the ways in which learning and memory have been implicated in drug addiction.
4.27.2 Associative Learning and Memory in Addiction
Associative learning and memory were implicated in addiction long before there were formal accounts of classical (Pavlov, 1927)
and instrumental (Skinner, 1938) conditioning or a description of multiple memory systems (e.g., habit learning, declarative
memory) (Squire, 1986). Nearly two centuries ago, the Scottish surgeon Robert Macnish described the difﬁculty of treating
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individuals with alcohol addiction in terms of a learned association between drugs and stimuli (e.g., people, places) driving
habitual drug taking (Macnish, 1834; Siegel, 1999):
Man is very much the creature of habit. By drinking regularly at certain times he feels the longing for liquor at the stated return of those periods.He
even feels it in certain companies, or in a particular tavern at which he is in the habit of taking his libations. We have all heard the story of the man who
could never pass an inn on the roadside without entering it and taking a glass.it is a good rule for drunkards to break all such habits.Let
him.forswear the society of boon companions.Let him, if he can manage it, remove from the place of his usual residence and go somewhere else.
Macnish (1834, p.208).
Early theories of the pathology in addiction, however, emphasized the role of physical dependence and withdrawal
(Himmelsbach, 1942). Although no formal theoretical analysis of the involvement of learning was performed, these changes
were generally thought of as nonassociative and involving processes like habituation, which at the time were often not regarded
as “learning” per se.
In 1965, Abraham Wikler laid out a theory of addiction in terms of associative learning theory. Wikler proposed a two-stage
model in which (1) neutral stimuli acquired conditioned responses associated with positively reinforced drug use via Pavlovian
classical conditioning; and (2) that chronic drug use was maintained via instrumental conditioning, particularly negative reinforce-
ment (Shaffer, 1984; Wikler, 1977, 1973, 1965; Wikler and Pescor, 1967). The observations that most drug classes directly or
indirectly engaged the “reward” pathway (Stewart et al., 1984; Volkow and Morales, 2015; Wise and Bozarth, 1987) and that
psychostimulants produce addiction without producing much physical dependence led to an emphasis on positive reinforcement.
Together, these reinforcement theories provided a framework upon which many contemporary cellular/molecular, behavioral
neuroscience, and cognitive models of addiction are built. Recently, much work has been devoted to identifying the neurocircuitry
and neurobiology underlying drug conditioning using both animal models and human neuroimaging (Bossert et al., 2013; Cruz
et al., 2013; Jasinska et al., 2014; Volkow and Morales, 2015).
4.27.2.1 Classical and Instrumental Drug Conditioning
It is now well established that stimuli (e.g., contexts, people, objects, internal states) can be classically conditioned to both the
“pleasurable/rewarding” effects of drugs of abuse (e.g., high, euphoria), as well as the withdrawal-induced aversive states associated
with drug abstinence (e.g., dysphoria, irritability, anxiety, pain). In other words, conditioned stimuli can produce both drug-like
and/or drug-opposite physiological and behavioral effects. These conditioned effects have been documented across drug classes
including opioids, psychostimulants, alcohol, and nicotine in both humans and animal models (Childress et al., 1999, 1986;
Droungas et al., 1995; Kaplan et al., 1985; Ludwig and Wikler, 1974; O’Brien et al., 1998; Sideroff and Jarvik, 1980).
The explanation as to why some conditioned stimuli produce drug-like effects, while others produce drug-opposite effects
remains unknown and is beyond the scope of this chapter (see Ehrman et al., 1992; Eikelboom and Stewart, 1982; Siegel, 1999;
Staiger and White, 1988 for discussions). Brieﬂy, it has been attributed to factors such as the type of stimulus (e.g., discrete consum-
matory versus preparatory environmental context), temporal pairing of the conditioned stimulus and the drug, the motivational
state of the animal, as well as the appropriate identiﬁcation of the unconditioned response (Eikelboom and Stewart, 1982).
Some conditioned stimuli even produce transient drug-like physiological effects followed by drug-opposite effects, as shown in
individuals with opioid or alcohol addiction (Staiger and White, 1988).
Regardless of how conditioned stimuli come to be associated with drug-like and/or drug-opposite effects, both conditioned
reward and conditioned aversive states have been hypothesized to contribute to subjective drug craving in humans (Childress
et al., 1986; Drummond et al., 1990; Gawin and Kleber, 1986; Koob, 2013; O’Brien et al., 1998; Siegel, 1989; Stewart et al.,
1984). Recently, it has been reported that individuals with addiction even exhibit progressive increases in their sensitivity (i.e.,
autonomic and behavioral responsiveness) to drug-paired cues the longer they abstain from a drug (Bedi et al., 2011), a phenom-
enon referred to as “incubation of craving” (Grimm et al., 2001).
In addition to classical conditioning, goal-directed instrumental conditioning, namely positive and negative reinforcement, has
been implicated in addiction. It is widely accepted that addictive drugs are positive reinforcers; they produce acute “pleasurable”
effects (e.g., euphoria/high in the case of psychostimulants and opioids, relaxation in the case of alcohol), which increase the
likelihood that the drug will be used again. It is hypothesized that drug-paired stimuli can become conditioned reinforcers and
thus, maintain drug seeking and taking either by positive incentive states (i.e., positive reinforcement) or by removing aversive states
(i.e., negative reinforcement) (Everitt and Robbins, 2016; Koob et al., 2014; O’Brien et al., 1998; Stewart et al., 1984). Indeed, some
evidence suggests that encounters with drug-paired cues are associated with relapse in humans (Heinz et al., 2009; Zhou et al.,
2009).
4.27.2.1.1 Conditioned Reward and Positive Reinforcement
In the 1920s, Light and Torrance (1929) described the phenomenon of conditioned reward: “It is not uncommon for one addict
to give another a hypodermic injection of sterile water and the recipient to derive a ‘kick’ and become quiet”. In this example, it
was hypothesized that injecting water alone was able to elicit a conditioned positive response, or “kick,” after needle injections
had been repeatedly associated with drug-induced euphoria (Levine, 1974; Meyer and Mirin, 1979; O’Brien, 1974). Thus, the
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injection produced a conditioned “drug-like” effect. O’Brien and others examined this phenomenon in a “seminaturalistic” drug-
taking environment; subjects were injected with an opioid antagonist and allowed to self-administer vehicle or opioids. Subjects
found both opioid and vehicle injections “pleasurable” (Meyer and Mirin, 1979; O’Brien, 1974). Gawin and Kleber (1986)
observed a similar response in a clinical setting with patients addicted to psychostimulants. Patients with cocaine addiction
reported intense positive craving when interacting with people with whom they had used cocaine, visiting neighborhoods in
which they had used drugs, or even when having blood drawn for standard medical procedures (Gawin and Kleber, 1986). In
animal models, psychostimulants induce hyperactivity and this effect can be conditioned to drug cues and contexts (Stewart
et al., 1984).
Neutral stimuli associated with the positive reinforcing or rewarding effects of addictive drugs are thought to acquire positive
motivational valence and increase drug seeking and taking when presented alone (Shaham et al., 2003, 1994; Stewart et al.,
1984). This has been modeled in animals using associative learning paradigms like conditioned place preference (CPP)
(Tzschentke, 2007, 1998). Generally, in CPP, one context is paired with drug administration and another is paired with vehicle.
For most drug classes, animals show a strong preference for the drug-paired context, indicating that the drug was rewarding
(Tzschentke, 2007, 1998). CPP is thought to reﬂect positive reinforcing, instrumental drug seeking, and/or Pavlovian approach
behavior in response to a drug-paired context (Tzschentke, 2007, 1998).
Positive reinforcement is often modeled in a self-administration paradigm, where an animal has to perform a behavior, such as
press a lever or nose poke, to receive a drug. Cue or context-induced reinstatement of drug seeking is frequently used to study the
motivational properties of drug-paired stimuli (Bossert et al., 2013; Crombag et al., 2008; Venniro et al., 2016). Here, animals are
trained to self-administer a drug in a particular context and with cues paired with drug intake. Next, instrumental responding is
extinguished in the absence of the drug and drug-associated cues or contexts. Instrumental responding can then be reinstated
following exposure to the drug cues or contexts. Incubation of craving, or the increased cue-induced drug seeking associated
with prolonged withdrawal, has been observed across drug classes and for rodents and nonhuman primates (Grimm et al.,
2001; Venniro et al., 2016; Weerts et al., 2006).
4.27.2.1.2 Conditioned Withdrawal-Induced Aversive States and Negative Reinforcement
In the 1950s Abraham Wikler observed that when patients with opioid addiction were talking about their drug use in therapy, they
would begin to exhibit physical signs of withdrawal (e.g., tearing eyes, running noses) even if they were detoxiﬁed and in protracted
abstinence. He reported that if individuals addicted to opioids were repeatedly injected with an opioid antagonist that precipitates
the effects of opioid withdrawal, eventually vehicle injections alone were able to elicit physiological and motivational (i.e., aversive
emotional states) withdrawal symptoms (Wikler, 1953). Charles O’Brien et al. (1998) continued this work and conducted
conditioning studies examining the effects of drug-related cues on behavior in human subjects addicted to opioids, cocaine, alcohol,
or nicotine. In a seminal experiment, abstinent patients addicted to heroin and maintained on methadone were repeatedly injected
with a very low dose of an opioid antagonist paired with a tone and peppermint odor (O’Brien et al., 1977). O’Brien et al. (1977)
found that presentation of the tone and odor along with a vehicle injection came to elicit both subjective reports of aversive states
and autonomic signs of withdrawal (e.g., increased respiration and heart rate).
Clinically, there have been numerous reports of conditioned withdrawal-induced aversive states in individuals with addiction
(Bradley et al., 1989; Khantzian, 1985; O’Brien, 1975; O’Brien et al., 1986; Unnithan et al., 1992; Wikler, 1973). Though we
described opioid examples here, conditioned aversive states have been found for most drug classes, including psychostimulants
(Ettenberg et al., 1999; Koob, 2013; Koob et al., 2014; Markou and Koob, 1991; Wenzel et al., 2014). It is hypothesized that stimuli
conditioned to withdrawal-induced aversive states can also acquire motivational signiﬁcance and lead to increased drug taking and
seeking when presented alone (Kenny et al., 2006; Kenny and Markou, 2005; Koob, 2013). An individual learns (1) that stimuli
paired with withdrawal are aversive (Pavlovian conditioning) and (2) that seeking and taking the drug will alleviate aversive states
(negative reinforcement) (Evans and Cahill, 2016).
Similar to conditioned reward, conditioned withdrawal-induced aversive states have been modeled in animals. Place
conditioning, speciﬁcally conditioned place aversion (CPA), is one popular model (Koob et al., 2014; Tzschentke, 2007, 1998).
In CPA, one context is paired with spontaneous or pharmacologically precipitated withdrawal and another is paired with vehicle.
Animals with chronic or repeated drug administration show a strong aversion for the context paired with withdrawal, reﬂecting its
negative motivational properties. In contrast to CPP, CPA in animal models is thought to reﬂect a negative reinforcing, instrumental
drug seeking behavior (Tzschentke, 2007, 1998). This paradigm has largely been tested with alcohol and opioids (Cunningham
et al., 2006; Gracy et al., 2001; Heinrichs et al., 1995; Stinus et al., 2005, 1990), but the phenomena extend to psychostimulants
(Ettenberg et al., 1999; Wenzel et al., 2014).
Conditioned withdrawal-induced aversive states have also beenmodeled in animals with chronic/repeated drug exposures using
electrical brain stimulation (i.e., ICSS), where drug cues conditioned to drug abstinence are able to elicit increased stimulation
thresholds, similar to those observed in drug withdrawal (Kenny et al., 2006; Kenny and Markou, 2005; Koob, 2013; Koob and
Le Moal, 1997). In a self-administration example, nonhuman primates taking morphine 24 h per day were repeatedly given
injections of an opioid antagonist paired with a light cue (Goldberg, 1976). Eventually, presentation of the light cue alone led
to an increase in morphine responding. A similar effect has been found in rats, with the added observation that presentation of
the cue alone induces a reward deﬁcit as measured by ICSS, suggesting that drug use may increase to overcome predicted reward
deﬁcits and to avoid the onset of withdrawal (Kenny et al., 2006; Kenny and Markou, 2005).
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4.27.2.2 Learning Theory in Theories of Addiction
The processes by which conditioned cues and contexts acquire motivational properties and individuals become more sensitive to
these stimuli over time are incompletely understood. From a learning theory perspective, the reinforcement or the “stamping in” of
an association (Thorndike, 1898) could happen between an unconditioned stimulus and a conditioned stimulus (Pavlov, 1927),
a stimulus and an outcome (Skinner, 1938), and/or a stimulus and a response (Rescorla, 1991; Thorndike, 1898). The encoding,
consolidation, and retrieval of each of these associations (i.e., the memory trace) can be strengthened by experience (Hogarth et al.,
2013; Rescorla, 1991; Wise, 2008). Conditioned stimuli, unconditioned stimuli, outcomes, and responses can become associated in
complex hierarchical relationships (Hogarth et al., 2013).
Different theories of addiction emphasize different aspects of learning (e.g., Pavlovian–instrumental transfer, conditioned
incentive learning), which will not be discussed in detail here (see, for examples, Di Chiara, 2002, 1999; Hogarth et al., 2013;
Robinson and Berridge, 2008; Torregrossa and Taylor, 2016). As an example, one theory suggests that aversive states set the stage
for enhanced acquisition of conditioned stimulus–unconditioned stimulus associations during abstinence. In other words,
abstinence enhances reward (heightens incentive learning) rather than promotes avoidance of withdrawal-induced aversive states
(negative reinforcement) (Di Chiara, 2002; Hutcheson et al., 2001; Smith and Aston-Jones, 2014). Conditioned aversive states
could also affect hedonic set points and enhance the efﬁcacy of positive reinforcement when a drug is used (stimulus–outcome
association) (Koob, 2013; Koob and Le Moal, 1997; Kreek and Koob, 1998).
Despite emphasizing different psychological mechanisms, most contemporary theories of addiction include a critical role for
conditioning factors and learned associations of positive incentive states or relief from aversive states. It remains an
open question, however, whether associative learning is what drives compulsivity in addiction and/or the transition from
controlled, recreational drug use to uncontrolled, compulsive drug seeking (O’Brien et al., 1998). Compulsivity can be deﬁned
as “perseverative, repetitive actions that are excessive and inappropriate” (Berlin and Hollander, 2014). In the laboratory,
compulsive drug seeking and taking are modeled in paradigms such as escalation of drug self-administration after extended
(Edwards and Koob, 2013) or chronic, intermittent (Kawa et al., 2016) access, increased responding in the face of punishment
or cost (e.g., progressive ratio, shift in behavioral economic demand or elasticity curves) (Kearns et al., 2016; Markou et al.,
1993; Pelloux et al., 2007), resistance to extinction (Markou et al., 1993), and habitual drug taking (resistance to deevaluation)
(Everitt and Robbins, 2016). Combining these paradigms with manipulations of molecular substrates or neurocircuitry implicated
in associative learning may reveal a shared role in compulsivity in addiction (discussed in section Approaches to Understanding the
Relationship Between Learning and Memory and Addiction).
4.27.2.3 Conditioning and Treatments for Addiction
Clinical anecdotes and experimental evidence support the hypothesis put forth by Wikler that at least some aspects of the drug
experience are able to be conditioned (Wikler, 1965, 1948). Conceptualizing addiction in terms of conditioning has provided
avenues for possible treatments. Treatments for addiction targeting the primary pharmacological actions of drugs of abuse have
been largely unsuccessful with the possible exception of naltrexone (Everitt, 2014; Koob and Mason, 2016; Torregrossa and Taylor,
2016). Thus, there has been great interest in identifying the mechanisms underlying addiction-related neuroadaptations because
extinction or induced amnesia of addiction-related memories could become a useful treatment for relapse and/or compulsive
drug seeking. Rawson et al. (1986) found that individuals addicted to cocaine were more likely to remain abstinent if they received
outpatient, rather than inpatient treatment. Gawin and Kleber (1986) attempted to explain this observation in terms of
conditioning. They proposed that those individuals in inpatient treatment were more likely to experience drug cue-elicited craving
because conditioned stimuli are often absent from the inpatient setting (Gawin and Kleber, 1986).
Cue exposure therapy attempts to prevent relapse by reducing the behavioral and physiological effects of drug cues through
repeated pairings of the cues in the absence of the drug (i.e., extinction). Extinction can reduce some of the conditioned physiolog-
ical effects elicited by drug cues as well as reduce subjective reports of craving (Everitt, 2014). Clinically, this approach has been
largely unsuccessful, possibly, for various reasons, including spontaneous recovery and context speciﬁcity during extinction therapy
(Conklin and Tiffany, 2002; Myers and Carlezon, 2012) [but see ﬁndings for individuals with alcohol addiction (MacKillop and
Lisman, 2008; Stasiewicz et al., 2007)].
Recent work aims to identify pharmacological agents that enhance extinction and/or reduce cue reactivity (Everitt, 2014; Jasinska
et al., 2014; Koob and Mason, 2016; Torregrossa and Taylor, 2016). Another approach is targeting memory reconsolidation, in
which a memory is reactivated by brieﬂy presenting drug conditioned stimuli (Lewis, 1979; Nader, 2015) followed by prolonged
extinction trials (i.e., “superextinction”). Reactivation of the cue engages molecular mechanisms involved in the initial consolida-
tion of the memory and the memory trace becomes labile (Nader, 2015). Xue et al. (2012) applied this procedure to individuals
addicted to heroin. First, abstinent subjects brieﬂy viewed a video of drug taking (memory reactivation). Then, the subjects viewed
the video for a longer period of time (engaging extinction processes). Subjects who underwent this procedure reported less
subjective craving and demonstrated decreased physiological responses when exposed to the video during a subsequent test.
Intriguingly, there was also a signiﬁcant reduction in relapse that persisted up to 6months later (Xue et al., 2012). In the same study,
Xue et al. (2012) showed that this effect could be modeled in animals: the memory retrieval-extinction procedure reduced
cue-induced reinstatement of drug seeking in cocaine or heroin-taking rats.
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4.27.3 Approaches to Understanding the Relationship Between Learning and Memory and Addiction
In the following sections, we describe three ways in which the relationship between learning, memory, and addiction has been
framed (Everitt and Robbins, 2016; Hyman, 2005; Kelley, 2004; Nestler, 2001; Robbins and Everitt, 1999; Volkow et al., 2003).
It is important to note that these frameworks are not mutually exclusive and that theories of addiction attempt an integrated view.
1. Learning, memory, and addiction interact, but are distinct processes.
2. Learning, memory, and addiction share neurocircuitry and molecular substrates.
3. Addiction as an example of pathological learning.
4.27.3.1 Learning, Memory, and Addiction Interact, but Are Distinct Processes
In this framework, addiction is thought to include aspects of associative learning and memory, but ultimately, other mechanisms
are thought to cause the behavior in addiction to be pathological. More speciﬁcally, while drug cue-elicited craving may share
neuroadaptations similar to those underlying traditional associative learning, the process of addiction includes behaviors and
neuroadaptations that are dissociable from associative learning and memory (e.g., sensitization, allostasis, loss of inhibitory
control) (Anagnostaras et al., 2002; Anagnostaras and Robinson, 1996; Koob, 2013; Koob and Le Moal, 1997; Robinson and
Berridge, 1993, 2008; Volkow et al., 2003; Volkow and Morales, 2015). From a treatment perspective, this view implies that
behavioral or pharmacological manipulations that selectively target associative learning andmemory mechanisms will have limited
efﬁcacy in treating addiction (but see Xue et al., 2012).
In the following quote, Nora Volkow, current director of the U.S. National Institute of Drug Abuse, describes a putative role for
learning and memory in addiction:
Memory systems are likely to be involved in the process of addiction via their inﬂuence on drug intoxication and craving. In drug intoxication, the
previously learned drug experience will set the expectations of the drug effects in the drug abuser, which in turn will affect his or her response to the
drug.Drug craving is associated with the learned response that links the drug and its environment to a pleasurable or an intensely overpowering
experience. The relevance these learned associations have on addiction is evidenced by the pernicious effect that a place, a person, or a cuedthat brings
back memories of the drugdhave on the addict who is trying to stay clean.
Volkow et al. (2002, p. 618).
In support of this role, early neuroimaging work using functional magnetic resonance imaging and positron emission tomog-
raphy in humans demonstrated that the amygdala and hippocampus, brain regions strongly linked to associative learning and
contextual and declarative memory, respectively, were strongly activated during drug intoxication (Stein et al., 1998) and craving
(Childress et al., 1999; Grant et al., 1996; Jasinska et al., 2014; Kilts et al., 2001).
Recent work combining drug cue reactivity paradigms with human neuroimaging has examined the neurocircuitry underlying
cue-elicited craving (Jasinska et al., 2014; Koob and Mason, 2016). In these tasks, subjects are exposed to drug cues (e.g., auditory,
visual, tactile, gustatory, or multisensory) while subjective and physiological reactivities are measured (Childress et al., 1999;
Jasinska et al., 2014; Volkow et al., 2009, 2003). Cue reactivity has been shown to correlate with addiction severity and treatment
effectiveness (Jasinska et al., 2014). In addition to the hippocampus and amygdala, salient drug cues evoke activity in the ventral
tegmental area (VTA), ventral striatum, anterior cingulate cortex, prefrontal cortex (PFC, including the orbitofrontal cortex and
dorsolateral PFC), and insula, as well as the dorsal striatum and sensory and motor cortices (Jasinska et al., 2014; Volkow et al.,
2011; Yalachkov et al., 2012).
From a neurocircuitry perspective, while learning and memory circuits may be involved, several other circuits are theorized to
be key to compulsivity and transition to addiction. For example, reward (ventral striatum and pallidum), motivation/drive
(orbitofrontal cortex), executive/inhibitory control (PFC and anterior cingulate gyrus), and stress circuits (extended amygdala,
ventral striatum, habenula) may all be dysfunctional (Koob and Volkow, 2016; Volkow et al., 2009, 2003). There is even some
evidence of dysfunctional perceptual and sensory processing circuits (Jasinska et al., 2014). One example of the importance of
dysregulation in circuits other than those implicated in learning and memory is the observation that abstinent individuals with
cocaine addiction have reduced dopamine release in the dorsal striatum, as well as reduced D2 receptor expression (Volkow
et al., 1997). This observation led to the notion that frontal-mediated executive control circuits have impaired ability to inhibit
habitual responding. Recently, treatment efﬁcacy in individuals with alcohol addiction has been linked to the degree of frontal
cortex executive dysfunction (Rando et al., 2011).
From a molecular perspective, addiction is hypothesized to recruit multiple forms of plasticity, which may only partially overlap
with the neural plasticity underlying traditional associative learning and memory (i.e., dopamine and glutamate signaling)
(Anagnostaras et al., 2002; Anagnostaras and Robinson, 1996; Koob and Volkow, 2016; Volkow et al., 2011; Volkow and Morales,
2015). For example, behavioral sensitization, the progressive increase in a behavioral response following repeated administration of
a drug, can develop in the absence of glutamate neurotransmission through N-methyl-D-aspartate (NMDA) receptors, a hallmark of
cellular models of associative learning and memory (Carmack et al., 2013). In the following two sections, we will describe two
theories of addiction in which nonassociative mechanisms are the ones hypothesized to be driving pathological behavior in
addiction.
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4.27.3.1.1 Positive Reinforcement Theories: Incentive Sensitization
The mesocorticolimbic dopamine pathway, particularly the projection from the VTA to the nucleus accumbens (ventral striatum in
humans), plays a key role in incentive salience, directing behavior toward salient stimuli (Schultz, 2007). It was frequently referred
to as the “reward” pathway (Wise, 2008), but incentive salience reﬂects a more accurate description of the functional attributes of
this system. Incentive salience is the motivation for a reward driven both by previously learned associations between conditioned
and unconditioned stimuli and an organism’s physiological state (Koob and Volkow, 2016). In a seminal study, Schultz et al.
(1997) demonstrated that VTA dopamine cells in nonhuman primates initially ﬁred action potentials in response to the delivery
of a predictable nondrug, food reward. Eventually, the cells ﬁred only when the subject was exposed to conditioned stimuli that
predicted the reward, but not to the reward itself (Schultz et al., 1997). Thus, it was hypothesized that the cue acquired incentive
salience.
The mesocorticolimbic dopamine pathway appears to be critically involved in the acute reinforcing actions of many classes of
drugs despite the different classes having diverse primary pharmacological actions. Direct or indirect drug-induced dopamine
release in the nucleus accumbens has been demonstrated for psychostimulants, opioids, nicotine, cannabinoids, and alcohol
(Volkow and Morales, 2015). In addition to dopamine, opioid peptides are required for the rewarding effects of opioids and
alcohol and contribute to the rewarding effects of psychostimulants and cannabinoids (Le Merrer et al., 2009; Volkow et al.,
2011). The VTA also has major dopaminergic projections to the dorsal striatum, amygdala, PFC, and anterior cingulate cortex
(Koob and Volkow, 2010; Swanson, 2000). There is a projection from the VTA to the hippocampus (Swanson, 2000), but there
is some debate as to whether or not this projection is dopaminergic (Broussard et al., 2012). Salient drug-paired stimuli induce
dopamine release in the dorsal and ventral striatum, amygdala, and PFC and opioid peptides in the anterior cingulate and frontal
cortex (Ito et al., 2002; Koob and Volkow, 2016; Stewart et al., 1984). Recent work using fast-scan cyclic voltammetry in rats has
found decreased dopamine release in the nucleus accumbens in response to cocaine following extended drug access in the
escalation of self-administration model (Willuhn et al., 2014), but a dramatic increase in dopamine release to drug-paired
cues (Burgeno et al., 2015). This work extends the seminal ﬁndings of Schultz et al. (1997) with food rewards to drug self-
administration.
According to the incentive sensitization theory of addiction, repeated, intermittent drug use causes the stored incentive value
of the drug to undergo nonassociative sensitization in which the unconditioned response to the drug progressively increases [i.e.,
stimulates more dopamine release in the nucleus accumbens/ventral striatum, but see Willuhn et al., (2014)]. This leads to
excessive motivation or attributed salience to the drug, drug cues, or emotional states (Robinson and Berridge, 1993, 2008).
This is reﬂected by increased dopamine release in response to drug-paired cues versus neutral cues, which motivates drug taking
even when the drug’s pharmacological effects have decreased as a result of chronic use (Koob and Mason, 2016; Schultz et al.,
1997; Volkow et al., 2014). As a result, individuals with addiction are driven to approach and pursue incentive cues, contexts, and
emotional states.
Associative learning is thought to contribute to the sensitized drug response through excitatory Pavlovian conditioning
producing an additional conditioned response and/or inhibitory occasion-setting gating the expression of sensitization in the
presence of contexts or cues where the drug is not expected (Anagnostaras et al., 2002; Anagnostaras and Robinson, 1996). An
alternative associative learning account to the incentive-sensitive sensitization theory posits that addiction develops as a result of
abnormal Pavlovian incentive learning, mediated by nonadaptive dopamine release in the nucleus accumbens shell (Di Chiara,
2002). In this conception, the acquisition of the incentive conditioned stimulus–unconditioned stimulus association is patholog-
ical, rather than the expression of the behavioral response.
4.27.3.1.2 Negative Reinforcement Theories: Opponent Process and Allostasis
In one negative reinforcement theory of addiction, homeostatic mechanisms such as allostasis (deﬁned as maintenance of
physiological stability with change, often a set point change) drive drug taking (Edwards and Koob, 2010; Koob and Le Moal,
1997; Siegel, 1999; Solomon and Corbit, 1974; Wikler, 1965). According to opponent process theories, it is theorized that
nonassociative, counteradaptive mechanisms cause allostasis or a long-lasting change in an organism’s hedonic set point
(Koob and Le Moal, 2001). Allostasis, in this context, could be termed hedonic allostasis and is reﬂected by the emergence of
an aversive state in individuals with addiction who are in withdrawal or protracted abstinence. Aversive states are thought to
be caused by (1) reduced reward system function, which can be measured using electrical brain stimulation in animal models
as well as responses to natural rewards (dysregulated mesocorticolimbic dopamine system) (Koob, 2013; Koob et al., 2014;
Koob and Le Moal, 1997; Volkow et al., 2003); and (2) the engagement of brain and hormonal stress systems (e.g.,
corticotropin-releasing factor, dynorphin, and norepinephrine recruitment in the extended amygdala and habenula) (Koob
et al., 2014). Aversive states occur across drug classes and can be paired to stimuli (Kenny et al., 2006; Kenny and Markou,
2005; Koob, 2013; Markou and Koob, 1991). Though hedonic allostasis is thought to be a nonassociative key factor driving
compulsivity and the transition to addiction, there is a role for associative learning in the form of (1) conditioned cues and
contexts, which could acquire incentive salience, and (2) aversive events activating a learned association of drug use to alleviate
aversive states (Evans and Cahill, 2016). For example, rats self-administering heroin were trained to associate a light and tone cue
with injections of an opioid antagonist. Eventually, rats increased heroin intake during presentation of the light and tone cue, but
in the absence of the antagonist, presumably to avoid the onset of withdrawal (Kenny et al., 2006). It is unknown whether such
conditioned stimuli sensitize, incubate, or otherwise follow the rules of stimuli paired with drug reward.
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4.27.3.2 Learning, Memory, and Addiction Share Molecular Substrates and Neural Circuits
In this framework, neuroadaptations as a result of drug exposure are thought to reﬂect the same neurobiological processes as
memory, particularly at the molecular level, because the brain likely has a limited number of plasticity mechanisms to remodel
synapses (Nestler, 2001). According to cellular and molecular theories of addiction, addiction is then seen as a type of drug-
induced neural plasticity (Hyman, 2005; Nestler, 2004; Russo et al., 2010). Similarly, memory and addiction are increasingly
thought to share a neural substrate, whereby learning caused by drug exposure produces neuroadaptations in the motivational
circuitry related to natural reward learning (Kelley, 2004), as well as other memory systems (Kutlu and Gould, 2016; White, 1996).
4.27.3.2.1 Molecular Substrates
Learning can be deﬁned as a relatively permanent change in behavior as the result of experience. Experiences are hypothesized to
modify synaptic plasticity in a way that is reﬂected in future behavior. Though it is unknown exactly how synaptic plasticity leads to
the encoding, storage, and retrieval of experiences (i.e., memory traces), synaptic plasticity appears to be required for all types of
memories (e.g., hippocampus for declarative memory, basal ganglia for habit learning) (Citri and Malenka, 2008; Kandel et al.,
2014; Mayford et al., 2012; Sweatt, 2016). The plasticity molecules recruited in various forms of learning and memory overlap
and are conserved across species, including aplysia, drosophila, mice, rats, and humans (Citri and Malenka, 2008; Kandel et al.,
2014; Mayford et al., 2012; Sweatt, 2016).
Cellular andmolecular models of associative learning andmemory have several well-established phenomena, including, but not
limited to, (1) associative stimulation activating glutamatergic a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)
and NMDA receptors at select synapses (Citri and Malenka, 2008); (2) calcium entry into the cell through NMDA receptors; (3)
activation of persistent protein kinases by signaling cascades [e.g., protein kinase A (PKA), protein kinase C (PKC), calcium/
calmodulin-dependent protein kinase II (CaMKII)] (Silva et al., 1992a, 1992b); (4) new gene transcription activated by calcium-
responsive transcription factors [e.g., cAMP response element–binding protein (CREB)] and protein synthesis (Josselyn et al.,
2001; Kida et al., 2002); (5) parallel processes in long-term potentiation and depression (LTP and LTD) (Bliss and Collingridge,
1993; Bliss and Lomo, 1973); and (6) structural remodeling of the neuronal synapse in an input-speciﬁc manner (Bailey et al.,
2015; Bosch et al., 2014). Interfering with these neuroplastic changes results in amnesia.
The speciﬁcity of drug cue conditioning and conditioned cue behaviors to individuals (Gawin and Kleber, 1986) led to the
hypothesis that one mechanism underlying addiction was synapse-speciﬁc associative learning (Hyman and Malenka, 2001).
Therefore, as summarized in the following quote, a major focus in drug addiction research has been to identify plasticity molecules:
Drugs of abuse cause long-lasting neural changes in the brain that underpin the behavioral abnormalities associated with drug addiction.the
molecular pathways of learning and memory on the one hand, and of drug addiction on the other, have converged. Learning and memory and drug
addiction are modulated by the same neurotrophic factors, share certain intracellular signaling cascades, and depend on activation of the transcription
factor CREB. They are associated with similar adaptations in neuronal morphology, such as the formation or loss of dendritic spines. Even more
compelling, they are accompanied by alterations in neural plasticity at glutamatergic synapses.
Nestler (2001).
There are many examples of shared molecular substrates between learning and memory and addiction, corresponding to steps
(1)–(5) (Carlezon et al., 1998; García-Pardo et al., 2016; Howell et al., 2014; Lüscher andMalenka, 2011; Nestler, 2004; Russo et al.,
2010; Thomas et al., 2009; Wolf and Ferrario, 2010). Only a few will be described here.
As described in section Positive Reinforcement Theories: Incentive Sensitization, the mesocorticolimbic dopamine pathway is
critical for the acute reinforcing effects of most drug classes. It is also involved in assigning incentive salience to drug-paired stimuli.
Therefore, the cellular/molecular biology of addiction ﬁeld has heavily focused on synaptic plasticity in this pathway. It has been
hypothesized that medium spiny neurons within the nucleus accumbens are “coincidence detectors” in associative learning in
addiction, in a manner similar to that of pyramidal cells within the cortex for learning and memory (Kelley, 2004). One hallmark
of LTP in the pyramidal hippocampal–PFC pathway is the coactivation of dopamine (D1) and glutamate receptors (Baldwin et al.,
2002). Here, glutamate is theorized to encode the speciﬁc sensorimotor experience, while dopamine is thought to detect rewarding,
salient events, or unpredictable events (Abel and Lattal, 2001; Kelley, 2004). A single exposure to psychostimulants has been shown
to induce LTP (potentiate AMPA currents) in VTA dopamine cells and this effect requires dopamine D1 receptors (Ungless et al.,
2001). Indeed, most drug classes evoke LTP- and LTD-like plasticity in VTA dopamine neurons (Lüscher and Malenka, 2011;
Volkow and Morales, 2015).
Drug-induced LTP- and LTD-like plasticity requires glutamatergic signaling through NMDA receptors (Russo et al., 2010;
Thomas et al., 2009). Glutamatergic inputs to the nucleus accumbens have been found from the amygdala, hippocampus, and
PFC (Volkow and Morales, 2015). Much evidence demonstrates altered glutamatergic and dopaminergic signaling following
chronic drug abuse, particularly in the nucleus accumbens, PFC, and VTA (Hotsenpiller and Wolf, 2003; Kenny et al., 2003a,b;
Koob et al., 1998; Koob and Volkow, 2016; Lovinger et al., 2003; Pierce et al., 1996; Pierce and Kalivas, 1997). A smaller literature
has also indicated alterations in the hippocampus and amygdala (Everitt et al., 2008, 2001).
At the behavioral level, blocking glutamate and dopamine signaling interferes with conditioned drug effects, including CPP, cue
and context-induced reinstatement, and incubation of craving (Bossert et al., 2011; Conrad et al., 2008; Schmidt et al., 2015;
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Tzschentke, 2007; Wolf, 1998). Administration of N-acetylcysteine, a drug that normalizes glutamatergic transmission in the
nucleus accumbens, to animals trained to self-administer cocaine enhances extinction learning and blocks cue-induced
reinstatement (Baker et al., 2003; LaRowe et al., 2013; Moran, 2005; Moussawi et al., 2011). In double-blind placebo-controlled
clinical trials, however, N-acetylcysteine has weak effects in humans (Gray et al., 2012; Heilig et al., 2016; LaRowe et al., 2013).
D-cycloserine, a partial agonist at the glycine site of the NMDA receptor, enhances extinction of drugmemories and has some efﬁcacy
in reducing cue reactivity in smokers, but is ineffective in individuals addicted to cocaine or alcohol (Myers and Carlezon, 2012).
In another example, the PKA pathway plays a major role in learning and memory (García-Pardo et al., 2016). Chronic exposure
to addictive drugs increases cAMP formation in the nucleus accumbens, which subsequently activates PKA and CREB (Carlezon
et al., 1998; Nestler, 2004). Interfering with this signaling pathway has profound effects on addiction-like behavior. Tonic activation
of the cAMP/PKA pathway promotes escalation of drug self-administration (Edwards and Koob, 2010; Self et al., 1998); blockade of
the pathway blocks reconsolidation of cued-cocaine memories (Sanchez et al., 2010).
As a ﬁnal example, chronic psychostimulant administration produces structural remodeling (increased spine density) in
medium spiny neurons of the nucleus accumbens (Robinson and Kolb, 1997; Russo et al., 2010). Increased spine formation
may occur following insertion of high-calcium-permeable AMPA receptors (Conrad et al., 2008). The protein kinase mTORC1 is
implicated in learning and memory as it mediates dendritic translation of synaptic proteins. Addictive drugs activate the mTORC1
pathway in the nucleus accumbens, as well as the hippocampus, PFC, and amygdala (Neasta et al., 2014). Blockade of this pathway
interferes withmemory reconsolidation and blocks cued reinstatement of alcohol seeking (Barak et al., 2013; Ron and Barak, 2016).
4.27.3.2.2 Neurocircuitry
Traditionally, the ﬁelds of learning and memory and of addiction have examined separate brain regions and brain circuits. The
addiction ﬁeld targeted the connections and terminals of the mesocorticolimbic dopamine system, while the memory ﬁeld focused
primarily on the hippocampus (declarative and contextual learning) and amygdala (associative conditioning) (Kandel et al., 2014;
Tonegawa et al., 2015; Volkow et al., 2003). Increasingly, the anatomical distinction between these two ﬁelds has blurred (Everitt
and Robbins, 2016; Goodman and Packard, 2016; Kelley, 2004; Kutlu and Gould, 2016; Rosen et al., 2015; White, 1996).
Experimental evidence strongly supports the existence of multiple memory systems mediated by distinct brain regions (e.g.,
hippocampus, amygdala, dorsal striatum) and neural circuits for encoding, consolidation, and retrieval (McDonald and White,
1993; Squire, 1986). Two decades ago, Norman White extended the multiple memory systems model to drug addiction (White,
1996), implicating the hippocampus in contextual control of drug seeking, the amygdala in conditioned associations between
stimuli and drug use, and the dorsal striatum in habitual drug seeking (Goodman and Packard, 2016). Converging ﬁndings
from human and animal studies support this view, demonstrating that behavioral phenomena associated with drug use (e.g.,
CPP, CPA, conditioned responding, reinstatement of self-administration) engage the hippocampus, amygdala, and dorsal
striatal-dependent memory systems (Everitt and Robbins, 2016; Goodman and Packard, 2016; Kelley, 2004; Kutlu and Gould,
2016; Rosen et al., 2015; White, 1996). For example, the basolateral amygdala is critical for cue-induced reinstatement of drug
seeking for psychostimulants, alcohol, and opioids (Bossert et al., 2013), as well as conditioned withdrawal produced by a condi-
tioned stimulus previously paired with an opioid antagonist in morphine-dependent rats (Schulteis et al., 2000); and speciﬁc
patterns of neuronal activity in the hippocampus are required for expression of cocaine-induced CPP (Trouche et al., 2016).
It is important to note that the multiple memory systems are not entirely independent of one another and indeed can interact or
even compete (Poldrack and Packard, 2003). This has been demonstrated for certain motor sequence learning and maze learning
tasks (Baudonnat et al., 2011; Goodman and Packard, 2016; Kathirvelu and Colombo, 2013; McDonald and White, 1993;
Schroeder et al., 2002). For example, hippocampus lesions in rats enhance acquisition of the dorsal striatal-dependent win–stay
version of the radial arm maze task (McDonald and White, 1993). Therefore, Goodman and Packard (2016) have advised caution
in assigning roles to memory systems in addiction. For instance, they suggest that drugs with addictive potential could modulate
habit learning by directly activating the dorsal striatum; alternatively, they could impair hippocampus function and therefore, indi-
rectly enhance dorsal striatal function (Goodman and Packard, 2016). This is an open area for investigation.
Recently, it has been theorized that drugs with addictive potential act, themselves, to directly enhance memory consolidation at
a cellular and/or systems level in multiple memory systems. This could then lead to increased drug seeking and taking (Goodman
and Packard, 2016; Rosen et al., 2015). At present, few studies have directly explored the neurocircuitry underlying consolidation of
drug memories (Gholizadeh et al., 2013; Hsu et al., 2002; Rosen et al., 2015; Tzschentke, 2007). Some evidence has implicated the
hippocampal–cortical (Anagnostaras et al., 2001; Maren, 2001) and basolateral amygdala–PFC circuits identiﬁed in the consolida-
tion of emotional (fear) memories (Frankland, 2004; Nader, 2015) in consolidation of drug-induced CPP (Rosen et al., 2015; Sun
et al., 2011; Tzschentke, 2007). Gholizadeh et al. (2013) used protein synthesis inhibition to show that early consolidation (0–6 h)
of morphine-induced CPP requires the basolateral amygdala, while late consolidation (6–12 h) requires the PFC (Gholizadeh et al.,
2013). The majority of research has instead focused on identifying the neurocircuitry-mediating acquisition and expression of drug
memories. In the following sections, we describe a few examples of overlap between the neuroanatomy underlying multiple
memory systems and drug addiction.
4.27.3.2.2.1 Hippocampus-Dependent Learning
The hippocampus has a well-established role in the formation of declarative memoriesdor the explicit knowledge of the relation-
ship between stimuli (Kutlu and Gould, 2016). One prominent feature of the hippocampus is its high degree of synaptic plasticity
(Citri and Malenka, 2008; Kandel et al., 2014), which is thought to enable the encoding of complex contextual and spatial
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information. The hippocampus is implicated in behaviors related to drug addiction (Goodman and Packard, 2016; Kutlu and
Gould, 2016). For example, the dorsal hippocampus is involved in context-induced reinstatement and CPP, particularly for
psychostimulants (Bossert et al., 2013; Trouche et al., 2016; Tzschentke, 2007). In recent work, Trouche et al. (2016) used a trans-
genic mouse model to selectively label neurons activated in the hippocampus during acquisition of cocaine-induced CPP.
Subsequent optogenetic silencing of these previously active neurons completely blocked the expression of cocaine CPP. At the
cellular level, acute or chronic administration of drugs with addictive potential modiﬁes hippocampal-dependent LTP (Kutlu
and Gould, 2016; Lüscher and Malenka, 2011). Additionally, opioids, psychostimulants, and alcohol interfere with neurogenesis
in the adult hippocampus (Eisch and Harburg, 2006; Golub et al., 2015), which may affect normal functioning.
Noteworthy, though certain drug-associated memories require the hippocampus, chronic drug exposure affects hippocampus-
dependent memory in both humans and animals. Individuals with opioid, psychostimulant, or alcohol addiction exhibit impaired
hippocampus-dependent memory, including episodic memories, even in protracted abstinence (Curran et al., 2001; Kutlu and
Gould, 2016; Wood et al., 2014). Animals given high doses of psychostimulants, alcohol, or opioids exhibit signiﬁcantly impaired
hippocampus-dependent learning on tasks such as contextual fear conditioning, spatial object recognition, Morris water maze, and
the T-maze (Belcher et al., 2008; Gulick and Gould, 2007; Kutlu and Gould, 2016; Mendez et al., 2008; North et al., 2013; Tramullas
et al., 2008; Wood et al., 2014; Zhou et al., 2015). In an attempt to reconcile these observations, Kutlu and Gould (2016)
hypothesized that initial exposure to low doses of psychostimulants and alcohol may actually enhance hippocampal function
(Wood et al., 2014) and promote the formation of drug–context associations, while later chronic or high dose drug use impairs
hippocampal function, resulting in reduced cognitive ﬂexibility, which prevents the reversal of maladaptive context associations
through new learning.
4.27.3.2.2.2 Mesocorticolimbic and Corticostriatal Reward Learning
It has been postulated that addictive drugs act on the same neurocircuits that are critical for normal reinforcement learning and that
this property is fundamental to their ability to establish behaviors associated with addiction (described in section Positive
Reinforcement Theories: Incentive Sensitization) (Kelley, 2004). The dopamine–glutamate interactions within the mesocorticolim-
bic and corticostriatal networks described earlier are thought to play a critical, integrative role in appetitive instrumental learning. In
support of this hypothesis, drug-induced dopamine release in the nucleus accumbens shell is three to ﬁve times higher than the
amount of dopamine released in response to natural reinforcers (Di Chiara, 2002; Wise, 2008). Further, dopamine release induced
by natural reinforcers generally undergoes one-trial habituation in the nucleus accumbens shell, but dopamine release in response
to drug administration or drug cue presentation does not habituate (Di Chiara et al., 1999). As such, drug addiction has been
referred to as a dopamine-dependent associative learning disorder, whereby appetitive instrumental learning is directed toward
drugs and conditioned stimuli (Di Chiara, 2002, 1999; Di Chiara et al., 1999) to the detriment of natural reinforcers (Koob,
2013; Volkow et al., 2003). In the strongest version of this argument, the mesolimbic and mesocortical dopamine systems
implicated in addiction are thought to be the same those involved in habit learning (discussed in more detail in the following
section) (Everitt and Robbins, 2016; Kelley, 2004).
4.27.3.3 Drug Addiction as an Example of Pathological Learning
Finally, addiction has been described as primarily a “disease of learning andmemory” (Hyman, 2005). In this conception, addictive
drugs are thought to hijack the adaptive mechanisms underlying the natural reinforcement (incentive) pathway and recruit
maladaptive habit learning directed at drug seeking and taking (Berke and Hyman, 2000; Everitt and Robbins, 2016; Hyman,
2005; Hyman and Malenka, 2001; Tiffany, 1990; Torregrossa and Taylor, 2016; White, 1996). The following quote captures this
view:
.addiction represents a pathological usurpation of the neural mechanisms of learning and memory that under normal circumstances serve to shape
survival behaviors related to the pursuit of rewards and cues that can predict them.
Hyman (2005).
Goal-directed instrumental learning is one of the phylogenetically oldest forms of behavioral adaptation; it enables organisms to
seek mates, avoid danger, ﬁght predators, and seek stimuli necessary for survival, such as food and water (Dickinson and Balleine,
1994; Kelley, 2004). The diverse molecular substrates underlying instrumental learning are thought to ensure speciﬁcity and
plasticity in this adaptive system. Interoceptive (e.g., thirst, hunger, internal timing) and external cues (e.g., smell of food) drive
behavior toward obtaining goals. The mesocorticolimbic dopamine system described in section Positive Reinforcement Theories:
Incentive Sensitization is theorized to be the neural reinforcement/reward/incentive pathway. According to the drug addiction as
pathological learning framework, addictive drugs ﬁrst “take over” the goal-directed incentive pathway (Hyman, 2005). Interoceptive
cues (e.g., craving or emotional states) and external cues (e.g., drug environments, drug paraphernalia, people) conditioned to drug
effects also now drive drug seeking and consumption (Everitt and Robbins, 2016).
As an individual progresses to addiction, it is theorized that there is a transition from goal-directed instrumental behavior to
automatic, habitual behavior (Tiffany, 1990) through engagement of spiraling basal ganglia–globus pallidus–thalamic cortical
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loops (Belin et al., 2009; Belin and Everitt, 2008; Everitt, 2014; Everitt and Robbins, 2016; Hyman, 2005; Hyman and Malenka,
2001). The nigrostriatal system is linked to habit/procedural learning and voluntary motor control and comprises mainly dopamine
projections from the substantia nigra to the caudate and putamen (dorsal striatum in humans) and globus pallidus. In this model,
repeated activation of the nucleus accumbens incentive system by drugs or conditioned stimuli engages the habit formation system,
particularly the dorsal striatum (Belin et al., 2009). Whereas goal-directed drug seeking is elicited by the anticipated incentive value
of the drug or drug-paired stimulus, habitual drug seeking is elicited by stimuli that have formed a direct association with the drug
seeking response (Everitt and Robbins, 2016; Hogarth et al., 2013; Robbins and Everitt, 1999; Torregrossa and Taylor, 2016). In
other words, presentation of the drug or drug cue automatically triggers behaviors aimed at obtaining the drug. This is hypothesized
to occur for both the pursuit of positive incentive states and perhaps also for the habitual avoidance of withdrawal-induced aversive
states (Koob and Volkow, 2016).
Evidence for a transition from the ventral to dorsal striatum comes from both human neuroimaging and animal models (Belin
and Everitt, 2008; Corbit et al., 2014, 2012; but see Willuhn et al., 2014; see the following for reviews Belin et al., 2009; Everitt,
2014; Everitt and Robbins, 2016; Torregrossa and Taylor, 2016). Neuroadaptations in the nucleus accumbens appear early into
drug use, while neuroadaptations in the dorsal striatum do not appear until much later (Letchworth et al., 2001). Additionally,
cue-induced reinstatement of cocaine self-administration involves dopamine and AMPA receptor modulation in the dorsal striatum
in rats with a long history of cocaine administration (Vanderschuren et al., 2005). In contrast, dopamine signaling in the nucleus
accumbens, but not the dorsal striatum (caudate nucleus), is required for the acquisition of conditioned amphetamine responding
(Taylor and Robbins, 1986). Recently, Willuhn et al. (2012) provided compelling evidence for this transition using in vivo cyclic
voltammetry to show that drug cue-evoked dopamine release in the dorsolateral striatum emerged over several weeks in rats self-
administering cocaine, while dopamine release in the nucleus accumbens core decreased over the same time period. Phasic dorsal
striatal dopamine release was completely blocked by nucleus accumbens core lesions, suggesting a hierarchical relationship between
the two regions (Willuhn et al., 2012). However, the transition in the neurocircuit was not related to compulsive or escalated
cocaine use in the animal model (Willuhn et al., 2012). Finally, drug cue-elicited activation of the dorsal striatum has been observed
in individuals with addiction across different drug classes; the magnitude of dorsal, but not ventral, striatal activation correlated
with addiction severity and how automatic a behavior was in response to presentation of a drug cue (Jasinska et al., 2014; Yalachkov
et al., 2012).
In addition to the recruitment of maladaptive habit learning following the usurpation of the incentive pathway, the process of
addiction is also theorized to involve pathological learning associated with negative reinforcement as part of the “dark side of
addiction”dor the reduced function of reward neurocircuitry and the recruitment of antireward systems (see section Negative
Reinforcement Theories: Opponent Process and Allostasis) (Koob et al., 2014; Koob and Le Moal, 2005). As described in section
Conditioned Withdrawal-Induced Aversive States and Negative Reinforcement, aversive-like responses are a common response to
acute withdrawal and protracted abstinence for all major classes of drugs with addictive potential. Individuals with addiction learn
both (1) that stimuli paired with drug withdrawal are aversive via classical conditioning (conditioned withdrawal) and (2) that
seeking and taking the drug will alleviate these aversive states (Evans and Cahill, 2016; Kenny et al., 2006; Koob et al., 2014).
The neural circuit that subserves this type of associative learning is hypothesized to overlap with the neural circuit underlying
aversive fear learning, which includes the basolateral amygdala, central nucleus of the amygdala, bed nucleus of the stria terminalis,
and periaqueductal gray (Avery et al., 2016; Janak and Tye, 2015; Maren, 2001; McNally et al., 2011; Sweatt, 2016), and possibly the
hippocampus (speciﬁcally recruited in contextual fear conditioning) (Anagnostaras et al., 2001; Gale et al., 2004). As with
unconditioned fear, this circuit is activated during unconditioned, acute drug withdrawal as measured by immediate-early gene
expression (Frenois et al., 2002; Gracy et al., 2001). Structures in this circuit have been implicated in the acquisition and expression
of conditioned withdrawal-induced aversive states (Evans and Cahill, 2016; Heinrichs et al., 1995; Schulteis et al., 2000; Stinus
et al., 1990; Wenzel et al., 2014). For example, basolateral amygdala lesions reduced the acquisition of conditioned withdrawal
to a light and tone cue paired with naloxone in opioid-dependent rats (Schulteis et al., 2000). A corticotrophin-releasing factor
(CRF) peptide antagonist injected into the central nucleus of the amygdala blocked the expression of CPA produced by an
opiate-antagonist injection in morphine-dependent rats (Heinrichs et al., 1995). Additionally, norepinephrine antagonism in
the central amygdala or bed nucleus of the stria terminalis prevented the acquisition of CPA for the delayed effects of cocaine
(i.e., negative/anxiogenic effects), but left CPP for the immediate effects of cocaine intact (Wenzel et al., 2014). Compared to
conditioned reward and habit learning, conditioned withdrawal has been relatively understudied. It remains an exciting and
open area for future research.
4.27.4 Conclusion
Associative learning and memory are clearly involved in components of addiction, particularly in relapse. Contexts, cues, and
affective states associated with drug use can trigger craving and goal-directed instrumental drug seeking and taking by a positive
incentive state or removal of an aversive state. After chronic or repeated use, drug seeking and craving may be driven by learned
associations and/or autonomous, habitual cue-conditioned behavior. Additionally, there is a signiﬁcant overlap between the
neurobiology of associative learning and memory and the neurobiology of addiction; they share many molecular substrates and
neurocircuits. As a result, current accounts of addiction include aspects of associative learning and memory; research on the neural
substrates of drug conditioning now dominate the literature. However, the transition from recreational to pathological and
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compulsive drug seeking may involve processes other than associative learning and memory, such as sensitization, allostasis, or loss
of inhibitory control. The long-lasting neuroadaptations underlying these components may only partially overlap with those
underlying traditional associative learning. Understanding the neurobiology of addiction-related “memories,” whether associative
or nonassociative, is necessary for development of effective treatments for addiction-related behaviors.
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